BFS
MDLN

Bradley Foster & Sargent’s Medline Inc MDLN Stock Holding History

Bradley Foster & Sargent’s Portfolio MDLN Stock Details MDLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$17.3M Buy
+389,457
New +$17.2M 0.27% 76

Other funds holding MDLN

CG
Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return
HFCIX
H&F Corporate Investors X San Francisco, California $2.8B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
LPC
Lone Pine Capital Greenwich, Connecticut $12.5B AUM 54.4% 1-Year Est. Return

Bradley Foster & Sargent's MDLN Position: Q1 2026 in Review

Bradley Foster & Sargent opened a new position in Medline Inc (MDLN) in Q1 2026: 389,457 shares worth $17.3M. The stake represents 0.27% of the portfolio and ranks #76 among its holdings.

314 funds tracked by Wall St. Rank hold MDLN as of Q1 2026.

  • Bradley Foster & Sargent held 389,457 shares of Medline Inc worth $17.3M as of Q1 2026.
  • Medline Inc was a new Bradley Foster & Sargent position in Q1 2026.
  • Medline Inc made up 0.27% of Bradley Foster & Sargent's portfolio in Q1 2026, its #76 holding.
  • 314 funds tracked by Wall St. Rank held Medline Inc as of Q1 2026.

Based on Bradley Foster & Sargent's 13F filing for Q1 2026, filed 15 May 2026.